SWK, SVB Amend Misonix Credit Facilities
Misonix amended its existing credit facility with SWK Funding to provide an additional $5 million of term loans and closed a new $20 million revolving credit facility with Silicon Valley Bank.
Misonix amended its existing credit facility with SWK Funding to provide an additional $5 million of term loans and closed a new $20 million revolving credit facility with Silicon Valley Bank.
Harrow Health amended its loan agreement with SWK Funding and its partners, extending the interest-only period and adding $5million available funding.
Cheetah Medical entered into a $20 million senior secured term loan agreement with SWK Funding, a subsidiary of SWK Holdings, a Dallas-based, healthcare-focused investment firm.
BIOLASE entered into a $12.5 million senior secured term loan agreement with SWK Funding.
Response Genetics said a group of lenders led by SWK Funding, as agent provided a $12 million term loan that matures on July 29, 2020. In connection with the closing, the company issued SWK a warrant to purchase common stock.